Related Experiment Video
Updated: May 7, 2026
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Rubella in Poland in 2011
Ewa Karasek1, Iwona Paradowska-Stankiewicz
1Department of Epidemiology, National Institute of Public Health - National Institute of Hygiene, Warsaw. ekarasek@pzh.gov.pl
Przeglad Epidemiologiczny
|September 18, 2013
Summary
Rubella incidence slightly increased in Poland in 2011, with the highest rates in young children. No congenital rubella cases were reported, but laboratory confirmation of rubella remains low.
Area of Science:
- Epidemiology
- Public Health
- Vaccinology
Background:
- Rubella elimination efforts are ongoing globally, aiming to prevent congenital rubella cases.
- Historically, limited rubella vaccination in Poland led to increased incidence in men, posing risks to susceptible pregnant women.
Purpose of the Study:
- To evaluate the 2011 rubella epidemiological situation in Poland.
- To assess rubella vaccination coverage in the general population and specific birth cohorts.
Main Methods:
- Analysis of national infectious disease and vaccination data for 2011.
- Classification of rubella cases according to European Centre for Disease Prevention and Control (ECDC) definitions.
Main Results:
- Rubella incidence saw a slight rise in 2011 (11.1/100,000), with 4,290 cases reported.
- The highest incidence was observed in 5- and 6-year-old children.
- Congenital rubella cases were absent in 2011, though rubella incidence remained higher in males than females.
Conclusions:
- The low proportion (0.2%) of laboratory-confirmed rubella cases in 2011 requires urgent improvement.
- Continued surveillance and vaccination strategies are crucial for rubella elimination.
Related Concept Videos
01:51Vaccinations
Overview
01:28Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
02:57Real Time RT-PCR
Real-time reverse transcription-polymerase chain reaction, or Real-time RT-PCR, is an analytical tool used to determine the expression level of target genes. The method involves converting mRNA to complementary DNA with the help of an enzyme known as reverse transcriptase, followed by the PCR amplification of the cDNA. These two processes can be performed simultaneously in a single tube or separately as a two-step reaction.
The real-time quantification of the number of amplified products is...
The real-time quantification of the number of amplified products is...
01:28Diphtheria
Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...